18:13 AI Improving Dose Decisions and Patient Outcomes in Oncology- with Shefali Kakar of Novartis
Host: Daniel Faggella
The growing use of AI‑driven modeling in clinical development is exposing how limited traditional, single‑study dose selection and patient assessme...